Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check54 days agoChange DetectedThe web page has removed significant content related to a clinical study on N-Acetyl Cysteine for treating therapy-resistant major depressive disorder, including details about the study's purpose, methodology, and contact information.SummaryDifference84%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and the addition of a new version revision. The focus appears to have shifted towards a more concise presentation of the study's purpose and location.SummaryDifference32%
Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.